Cross Country Healthcare Inc
CCRNDelisted Jul 21, 2026- Industry
- Services-Help Supply Services
- SEC CIK
- 0001141103
Cross Country Healthcare Inc was delisted on Jul 21, 2026; its insiders filed their last Form 4 on Jul 21, 2026; 150 institutions reported holding it in 13F filings for Q2 2026, worth $377.3M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Cross Country Healthcare Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 233
- +33 vs. Q3 2022
- Shares held
- 35.9M
- −502.8K (−1.4%) vs. Q3 2022
- Total value
- $953.6M
- −$78.1M (−7.6%) vs. Q3 2022
- New holders
- 60
- 66 more added
- Sold out
- 27
- 85 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $377.3M |
| Q1 2026 | 151 | $267.0M |
| Q4 2025 | 147 | $211.1M |
| Q3 2025 | 169 | $450.1M |
| Q2 2025 | 162 | $411.2M |
| Q1 2025 | 161 | $489.2M |
| Q4 2024 | 175 | $577.5M |
| Q3 2024 | 180 | $470.2M |
| Q2 2024 | 162 | $478.1M |
| Q1 2024 | 175 | $666.0M |
| Q4 2023 | 174 | $834.7M |
| Q3 2023 | 189 | $920.6M |
| Q2 2023 | 194 | $1.04B |
| Q1 2023 | 201 | $842.4M |
| Q4 2022 | 233 | $953.6M |
| Q3 2022 | 203 | $1.04B |
| Q2 2022 | 182 | $752.7M |
| Q1 2022 | 195 | $767.3M |
| Q4 2021 | 185 | $943.9M |
| Q3 2021 | 161 | $729.1M |
| Q2 2021 | 152 | $563.7M |
| Q1 2021 | 129 | $425.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cross Country Healthcare Inc; share changes are against Q3 2022.